DK4008721T3 - Syntese af boronester og syre forbindelser - Google Patents

Syntese af boronester og syre forbindelser Download PDF

Info

Publication number
DK4008721T3
DK4008721T3 DK21197526.3T DK21197526T DK4008721T3 DK 4008721 T3 DK4008721 T3 DK 4008721T3 DK 21197526 T DK21197526 T DK 21197526T DK 4008721 T3 DK4008721 T3 DK 4008721T3
Authority
DK
Denmark
Prior art keywords
synthesis
acid compounds
boron esters
boron
esters
Prior art date
Application number
DK21197526.3T
Other languages
English (en)
Inventor
Fraser I Pickersgill
John Bishop
Young Lo
Fang-Ting Chui
Vithalanand R Kulkarni
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34968044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK4008721(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Application granted granted Critical
Publication of DK4008721T3 publication Critical patent/DK4008721T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK21197526.3T 2004-03-30 2005-03-24 Syntese af boronester og syre forbindelser DK4008721T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55753504P 2004-03-30 2004-03-30
EP11167263A EP2377868A1 (en) 2004-03-30 2005-03-24 Synthesis of Bortezomib

Publications (1)

Publication Number Publication Date
DK4008721T3 true DK4008721T3 (da) 2024-03-25

Family

ID=34968044

Family Applications (4)

Application Number Title Priority Date Filing Date
DK18172486.5T DK3385267T3 (da) 2004-03-30 2005-03-24 Syntese af boronestere og syreforbindelser
DK05742865.8T DK1756121T3 (da) 2004-03-30 2005-03-24 Syntese af borester- og borsyreforbindelser
DK11167264.8T DK2377869T3 (da) 2004-03-30 2005-03-24 Syntese af Bortezomib
DK21197526.3T DK4008721T3 (da) 2004-03-30 2005-03-24 Syntese af boronester og syre forbindelser

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DK18172486.5T DK3385267T3 (da) 2004-03-30 2005-03-24 Syntese af boronestere og syreforbindelser
DK05742865.8T DK1756121T3 (da) 2004-03-30 2005-03-24 Syntese af borester- og borsyreforbindelser
DK11167264.8T DK2377869T3 (da) 2004-03-30 2005-03-24 Syntese af Bortezomib

Country Status (41)

Country Link
US (14) US7714159B2 (da)
EP (5) EP2377868A1 (da)
JP (4) JP4558039B2 (da)
KR (1) KR100939598B1 (da)
CN (5) CN108329337B (da)
AR (3) AR049374A1 (da)
AT (1) ATE521612T1 (da)
AU (1) AU2005230930B2 (da)
BR (1) BRPI0509587A (da)
CA (4) CA2859119A1 (da)
CL (2) CL2010000350A1 (da)
CR (1) CR8653A (da)
CY (3) CY1112053T1 (da)
DK (4) DK3385267T3 (da)
DO (1) DOP2011000293A (da)
EA (1) EA012927B1 (da)
EC (1) ECSP066960A (da)
ES (3) ES2899606T3 (da)
FI (1) FI4008721T3 (da)
HK (4) HK1100004A1 (da)
HR (4) HRP20212002T1 (da)
HU (1) HUE056859T2 (da)
IL (3) IL178250A (da)
LT (2) LT3385267T (da)
ME (1) ME01975B (da)
MX (1) MX367324B (da)
MY (1) MY145427A (da)
NL (3) NL1028639C2 (da)
NO (4) NO338905B1 (da)
NZ (3) NZ598172A (da)
PE (3) PE20110075A1 (da)
PL (4) PL1756121T3 (da)
PT (4) PT4008721T (da)
RS (4) RS62738B1 (da)
SG (5) SG182999A1 (da)
SI (3) SI3385267T1 (da)
TW (1) TWI386212B (da)
UA (1) UA90108C2 (da)
UY (3) UY28830A1 (da)
WO (1) WO2005097809A2 (da)
ZA (1) ZA200608689B (da)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
CA2859119A1 (en) 2004-03-30 2005-10-20 Millenium Pharmaceuticals, Inc. Synthesis of boronic ester and acid compounds
WO2008075376A1 (en) * 2006-12-18 2008-06-26 Natco Pharma Limited Polymorphic forms of bortezomib and process for their preparation
WO2009004350A1 (en) * 2007-07-03 2009-01-08 Pliva Hrvatska D.O.O. Methods for preparing bortezomib and intermediates used in its manufacture
AU2016253697A1 (en) * 2007-08-06 2016-11-24 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
EA034601B1 (ru) * 2007-08-06 2020-02-25 Милленниум Фармасьютикалз, Инк. Способ получения бороновых кислот
CA2695082C (en) * 2007-08-06 2015-07-28 Millennium Pharmaceuticals, Inc. Peptide boronic acid and boronic ester compounds as proteasome inhibitors
US7442830B1 (en) 2007-08-06 2008-10-28 Millenium Pharmaceuticals, Inc. Proteasome inhibitors
US20110118274A1 (en) * 2007-08-23 2011-05-19 Cornell Research Foundation, Inc. Proteasome inhibitors and their use in treating pathogen infection and cancer
KR20100051828A (ko) * 2007-09-12 2010-05-18 닥터 레디스 레보러터리즈 리미티드 보르테조밉 및 그의 제조방법
US7838673B2 (en) 2007-10-16 2010-11-23 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
US20090325903A1 (en) 2008-06-17 2009-12-31 Millennium Pharmaceuticals, Inc. Boronate ester compounds and pharmaceutical compositions thereof
AR075090A1 (es) 2008-09-29 2011-03-09 Millennium Pharm Inc Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
AU2013204896A1 (en) * 2008-09-29 2013-05-16 Millennium Pharmaceuticals, Inc. Derivatives of 1-amino-2-cyclobutylethylboronic acid
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
CN101899062B (zh) * 2009-05-26 2015-04-15 上海威智医药科技有限公司 α-手性硼酸及硼酸酯的合成工艺
EP2270019A1 (en) 2009-06-19 2011-01-05 LEK Pharmaceuticals d.d. New synthetic route for the preparation of alpha-amino boronic esters
EP2280016A1 (en) 2009-07-27 2011-02-02 LEK Pharmaceuticals d.d. New synthetic route for the preparation of alpha-amino boronic esters via substituted alk-1-ynes
JP2012530115A (ja) 2009-06-19 2012-11-29 レツク・フアーマシユーテイカルズ・デー・デー 置換アルカ−１−インを経由するα−アミノボロン酸誘導体の調製のための新規な合成経路
WO2011087822A1 (en) 2009-12-22 2011-07-21 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
WO2011090940A1 (en) 2010-01-19 2011-07-28 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutic delivery
CA2789400A1 (en) 2010-02-09 2011-08-18 Ranbaxy Laboratories Limited Process for the preparation of bortezomib
CN101781326B (zh) * 2010-02-11 2013-08-21 福建南方制药股份有限公司 一种制备手性氨基硼酸的中间体及其制备方法
WO2011107912A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Polymorphic forms of bortezomib
KR101530942B1 (ko) * 2010-03-18 2015-06-23 이노파르마, 인코포레이티드 안정한 보르테조밉 포뮬레이션
US8263578B2 (en) 2010-03-18 2012-09-11 Innopharma, Inc. Stable bortezomib formulations
MX2012011298A (es) 2010-03-31 2012-11-06 Millennium Pharm Inc Derivados del acido 1-amino-2-ciclopropiletilboronico.
CN101812026B (zh) * 2010-04-12 2013-08-28 亚邦医药股份有限公司 一种硼替佐米的合成方法
JP5881254B2 (ja) 2010-05-18 2016-03-09 セルリアン・ファーマ・インコーポレイテッド 自己免疫疾患およびその他の疾患の治療のための組成物および方法
EP2627636B1 (en) 2010-10-14 2015-09-02 Synthon BV Process for making bortezomib and the intermediates for the process
TW201309303A (zh) 2011-03-03 2013-03-01 Cephalon Inc 用於治療狼瘡的蛋白酶體抑制劑
CN102206188B (zh) * 2011-04-08 2013-02-27 苏州二叶制药有限公司 N-(吡嗪-2-基羰基)-l-苯丙氨酸的制备方法
US8497374B2 (en) 2011-05-12 2013-07-30 Scinopharm Taiwan, Ltd. Process for preparing and purifying bortezomib
CN102268029B (zh) * 2011-05-19 2013-10-09 苏州二叶制药有限公司 化合物（1s,2s,3r,5s）-蒎烷二醇-l-苯丙氨酸-l-亮氨酸硼酸酯的制备
JP5944986B2 (ja) 2011-06-22 2016-07-05 セファロン、インク． プロテアソーム阻害剤、ならびにそれらの調製、精製、および使用のためのプロセス
CN102351890B (zh) * 2011-09-30 2014-07-02 重庆泰濠制药有限公司 一种硼替佐米的合成方法
CN102492021B (zh) * 2011-12-13 2013-10-23 重庆泰濠制药有限公司 硼替佐米的制备工艺
MX352652B (es) 2011-12-22 2017-12-04 Ares Trading Sa Inhibidores de inmunoproteasoma selectivos de derivados del acido alfa-amino boronico.
CN103374026A (zh) * 2012-04-27 2013-10-30 重庆医药工业研究院有限责任公司 一种硼替佐米中间体的制备方法
CN103450331B (zh) * 2012-06-05 2016-05-25 山东新时代药业有限公司 一种硼替佐米的精制方法
MX2015003175A (es) * 2012-09-11 2015-07-14 Cipla Ltd Proceso para preparacion de bortezomib.
WO2014072985A1 (en) 2012-11-06 2014-05-15 Natco Pharma Limited Novel boronic acid derivatives as anti cancer agents
EP2919786A4 (en) 2012-11-16 2016-06-01 Shilpa Medicare Ltd PROCESS FOR PREPARING CRYSTALLINE BORTEZOMIB
US9422314B2 (en) 2012-12-07 2016-08-23 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors
CN103897026A (zh) * 2012-12-29 2014-07-02 朱继东 硼替佐米关键中间体的晶型，制备方法及其运用
CN103897027A (zh) * 2012-12-29 2014-07-02 曹亚英 关键中间体晶型，制备方法及其在硼替佐米合成中的运用
ES2730013T3 (es) 2013-01-10 2019-11-07 Venatorx Pharmaceuticals Inc Inhibidores de betalactamasa
WO2014170628A1 (en) 2013-04-16 2014-10-23 Cipla Limited Process for the preparation of bortezomib mannitol ester
CN104211758B (zh) * 2013-05-29 2020-06-12 深圳翰宇药业股份有限公司 一种硼替佐米的制备方法
CN103497233B (zh) * 2013-09-30 2015-04-08 哈药集团技术中心 一种硼替佐米的制备方法
CN103554219A (zh) * 2013-10-01 2014-02-05 昆明贵研药业有限公司 一种制备硼替佐米的方法
KR101691353B1 (ko) * 2013-12-09 2016-12-30 주식회사 경보제약 보르테조밉의 제조방법 및 그의 신규 중간체
WO2015117136A1 (en) 2014-02-03 2015-08-06 Ohio State Innovation Foundation Boronic acid esters and pharmaceutical formulations thereof
SG11201609259VA (en) 2014-05-20 2016-12-29 Millennium Pharm Inc Boron-containing proteasome inhibitors for use after primary cancer therapy
RU2686740C2 (ru) 2014-06-11 2019-04-30 Венаторкс Фармасьютикалс, Инк. Ингибиторы бета-лактамазы
JP6420629B2 (ja) * 2014-10-30 2018-11-07 ボーグワーナー インコーポレーテッド チェーンガイドおよびチェーンテンショナアーム
DE102015204151A1 (de) * 2015-03-09 2016-09-15 Adidas Ag Ball, insbesondere Fußball, und Verfahren zur Herstellung eines Balls
JP6223508B2 (ja) * 2016-06-27 2017-11-01 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． プロテアソーム阻害剤
US10889600B2 (en) 2016-08-04 2021-01-12 VenatoRx Pharmaceuticals, Inc. Boron-containing compounds
CN110312727A (zh) * 2017-02-17 2019-10-08 费森尤斯卡比肿瘤学有限公司 一种改进的制备硼酸酯的方法
EP3592362A4 (en) 2017-03-06 2020-09-02 Venatorx Pharmaceuticals, Inc. SOLID FORMS AND COMBINATION COMPOSITIONS WITH A BETA LACTAMASE INHIBITOR AND USES THEREOF
US11267826B2 (en) 2017-05-26 2022-03-08 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
WO2018218190A1 (en) 2017-05-26 2018-11-29 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
WO2019020099A1 (zh) 2017-07-28 2019-01-31 成都地奥九泓制药厂 一种硼酸酯化合物、其合成方法及其用途
CA3074247A1 (en) * 2017-09-02 2019-03-07 Sun Pharmaceutical Industries Limited Process for the preparation of ixazomib citrate
CN111187336B (zh) * 2018-11-14 2022-05-20 正大天晴药业集团股份有限公司 硼替佐米的精制方法
US11964993B2 (en) 2021-07-03 2024-04-23 Shilpa Pharma Lifesciences Limited Crystalline bortezomib process

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525309A (en) 1983-03-15 1985-06-25 Washington State University Research Foundation, Inc. Lewis acid catalysis of the homologation of boronic esters with haloalkylmetal reagents
US4537773A (en) 1983-12-05 1985-08-27 E. I. Du Pont De Nemours And Company α-Aminoboronic acid derivatives
US4499082A (en) 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
US4701545A (en) 1986-02-12 1987-10-20 Washington State University Research Foundation, Inc. Preparation of α,α-dihaloalkyl boronic esters
US5250720A (en) 1987-06-05 1993-10-05 The Dupont Merck Pharmaceutical Company Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases
US5242904A (en) 1987-06-05 1993-09-07 The Dupont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0315574A3 (de) 1987-11-05 1990-08-22 Hoechst Aktiengesellschaft Renin-Inhibitoren
US5106948A (en) 1988-05-27 1992-04-21 Mao Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
DK3078667T3 (da) * 2001-01-25 2019-01-07 The United States Of America Represented By The Sec Dep Of Health And Human Services Formulering af borsyreforbindelser
WO2003033507A1 (fr) * 2001-10-12 2003-04-24 Kyorin Pharmaceutical Co., Ltd. Derives d'acide benzylmalonique et inhibiteurs de proteasomes les contenant
WO2003033506A1 (fr) * 2001-10-12 2003-04-24 Kyorin Pharmaceutical Co., Ltd. Derive d'acide d'aminoborane et medicament inhibiteur de proteasomes le contenant
CA2859119A1 (en) * 2004-03-30 2005-10-20 Millenium Pharmaceuticals, Inc. Synthesis of boronic ester and acid compounds
WO2009004350A1 (en) * 2007-07-03 2009-01-08 Pliva Hrvatska D.O.O. Methods for preparing bortezomib and intermediates used in its manufacture
US7838673B2 (en) * 2007-10-16 2010-11-23 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
JP2012530115A (ja) * 2009-06-19 2012-11-29 レツク・フアーマシユーテイカルズ・デー・デー 置換アルカ−１−インを経由するα−アミノボロン酸誘導体の調製のための新規な合成経路

Also Published As

Publication number Publication date
NZ550522A (en) 2010-08-27
JP2013100378A (ja) 2013-05-23
DK3385267T3 (da) 2021-11-01
US20050240047A1 (en) 2005-10-27
RS65253B1 (sr) 2024-03-29
UA90108C2 (uk) 2010-04-12
EA012927B1 (ru) 2010-02-26
IL219856A0 (en) 2012-06-28
AU2005230930A1 (en) 2005-10-20
CN103396427B (zh) 2018-04-13
TWI386212B (zh) 2013-02-21
NO343966B1 (no) 2019-07-29
NO338905B1 (no) 2016-10-31
UY35578A (es) 2016-01-08
JP6193960B2 (ja) 2017-09-06
PT3385267T (pt) 2021-11-23
CA2738706C (en) 2014-10-14
CA2853272A1 (en) 2005-10-20
SG10201600029PA (en) 2016-02-26
NO20064893L (no) 2006-12-22
NO20171939A1 (no) 2006-12-22
RS62738B1 (sr) 2022-01-31
NL1033189A1 (nl) 2007-10-22
ES2457593T3 (es) 2014-04-28
NL1028639A1 (nl) 2005-10-20
SI3385267T1 (sl) 2022-04-29
DK1756121T3 (da) 2012-01-09
US10000529B2 (en) 2018-06-19
MY145427A (en) 2012-02-15
CY1124753T1 (el) 2022-07-22
PE20110075A1 (es) 2011-02-17
ZA200608689B (en) 2007-09-26
AR097309A2 (es) 2016-03-02
AR049374A1 (es) 2006-07-26
UY28830A1 (es) 2005-09-30
NL1033190A1 (nl) 2007-04-23
AR097310A2 (es) 2016-03-02
CR8653A (es) 2007-10-23
TW200616646A (en) 2006-06-01
SG10201800972PA (en) 2018-03-28
US7714159B2 (en) 2010-05-11
CN111925385B (zh) 2023-11-21
EP3385267B1 (en) 2021-09-29
CN1960996B (zh) 2016-04-20
HK1257298A1 (zh) 2019-10-18
ES2371652T3 (es) 2012-01-05
IL219856A (en) 2015-05-31
KR20070007873A (ko) 2007-01-16
US20150038706A1 (en) 2015-02-05
MX367324B (es) 2019-08-15
SG182998A1 (en) 2012-08-30
DOP2011000293A (es) 2011-12-15
LT3385267T (lt) 2021-11-10
EP1756121B1 (en) 2011-08-24
IL219853A (en) 2015-05-31
HK1100004A1 (en) 2007-08-31
DK2377869T3 (da) 2014-04-14
CN1960996A (zh) 2007-05-09
IL178250A0 (en) 2006-12-31
WO2005097809A3 (en) 2006-02-16
US20200369722A1 (en) 2020-11-26
JP5894952B2 (ja) 2016-03-30
CA2560886C (en) 2014-08-12
CA2738706A1 (en) 2005-10-20
JP2010241816A (ja) 2010-10-28
EP2377869A1 (en) 2011-10-19
ECSP066960A (es) 2006-12-20
CL2010000350A1 (es) 2011-01-28
HRP20212002T1 (hr) 2022-04-01
EP4008721A1 (en) 2022-06-08
US20190330270A1 (en) 2019-10-31
HRP20140339T1 (hr) 2014-05-09
PL2377869T3 (pl) 2014-07-31
US20200157143A1 (en) 2020-05-21
JP4558039B2 (ja) 2010-10-06
SI1756121T1 (sl) 2012-03-30
NO344610B1 (no) 2020-02-10
NO20161350A1 (no) 2006-12-22
CY1112053T1 (el) 2015-11-04
US20210395301A1 (en) 2021-12-23
PL4008721T3 (pl) 2024-05-13
EP4008721B1 (en) 2024-01-03
CL2014002252A1 (es) 2014-12-05
PL1756121T3 (pl) 2012-02-29
EP2377868A1 (en) 2011-10-19
PL3385267T3 (pl) 2022-02-14
CN108329337A (zh) 2018-07-27
NL1033190C2 (nl) 2007-11-27
PT1756121E (pt) 2011-11-30
KR100939598B1 (ko) 2010-02-01
PE20060162A1 (es) 2006-04-07
ATE521612T1 (de) 2011-09-15
CN111925385A (zh) 2020-11-13
NL1033189C2 (nl) 2008-08-14
RS53259B (en) 2014-08-29
US20100174072A1 (en) 2010-07-08
HRP20110846T1 (hr) 2011-12-31
HK1246300A1 (zh) 2018-09-07
EP1756121A2 (en) 2007-02-28
AU2005230930B2 (en) 2011-09-29
HUE056859T2 (hu) 2022-03-28
EP3385267A1 (en) 2018-10-10
US9862745B2 (en) 2018-01-09
WO2005097809A2 (en) 2005-10-20
SG151322A1 (en) 2009-04-30
US20180265546A1 (en) 2018-09-20
ES2899606T3 (es) 2022-03-14
UY34969A (es) 2015-02-27
JP5414625B2 (ja) 2014-02-12
US20190112334A1 (en) 2019-04-18
US20160362449A1 (en) 2016-12-15
NZ586824A (en) 2012-03-30
SG182999A1 (en) 2012-08-30
HRP20240307T3 (hr) 2024-05-10
NZ598172A (en) 2013-08-30
US8283467B2 (en) 2012-10-09
CY1115336T1 (el) 2017-01-04
PE20142402A1 (es) 2015-02-04
ME01975B (me) 2015-05-20
NL1028639C2 (nl) 2007-01-17
RS51983B (en) 2012-02-29
US20130005968A1 (en) 2013-01-03
CN103396427A (zh) 2013-11-20
IL219853A0 (en) 2012-06-28
CA2859119A1 (en) 2005-10-20
JP2007530687A (ja) 2007-11-01
BRPI0509587A (pt) 2007-09-25
PT2377869E (pt) 2014-04-15
EA200601795A1 (ru) 2007-04-27
PT4008721T (pt) 2024-03-21
NO20191065A1 (no) 2006-12-22
CA2560886A1 (en) 2005-10-20
US20220204558A1 (en) 2022-06-30
CN107474062A (zh) 2017-12-15
FI4008721T3 (fi) 2024-03-19
HK1164320A1 (en) 2012-10-19
US20180044377A1 (en) 2018-02-15
JP2016056180A (ja) 2016-04-21
EP2377869B1 (en) 2014-01-29
SI2377869T1 (sl) 2014-05-30
LT4008721T (lt) 2024-03-25
CN108329337B (zh) 2021-06-25
US20210171574A1 (en) 2021-06-10
IL178250A (en) 2012-06-28

Similar Documents

Publication Publication Date Title
DK4008721T3 (da) Syntese af boronester og syre forbindelser
DK1778618T3 (da) Syntese af triethylentetraminer
LTPA2017004I1 (lt) Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
DK1831154T3 (da) Fremstilling af pregabalin og relaterede forbindelser
DK1871738T3 (da) N-alkylcarbonylaminosyreester- og N-alkylcarbonylaminolactonforbindelser og deres anvendelse
DK3121169T3 (da) Fremgangsmåder til syntese og/eller oprensning af diaminophenothiaziniumforbindelser
DK1824475T3 (da) Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol
DK1802579T3 (da) Derivater af 3-arylaminopyridin
DK1937824T3 (da) Sammensætninger af tRNA og anvendelser deraf
DK2167523T3 (da) Syntese og anvendelse af anti-reverse phosphorothioatanaloger af messenger-rna-cappen
DK1716115T3 (da) Syntese af acyloxyalkylcarbamat-prodrug og mellemprodukter deraf
DK1658295T3 (da) Regioselektiv syntese af CCI-779
DK2402005T3 (da) Formuleringer med langvarig frigivelse af nalbuphin
DK1937071T3 (da) Krystallinske modifikationer af pyraclostrobin
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
DK1848705T3 (da) EXO- og diastereoselektive synteser af himbacin-analoger
CY2013035I1 (el) Μεθοδοι χρησης συνθεσεων αμινοπυριδινης παρατεταμενης αποδεσμευσης
DK2099796T3 (da) Aza-indolyl-forbindelser og fremgangsmåder for anvendelse
NO20043305D0 (no) Preparation of lodixanol
DK1721965T3 (da) Fremgangsmåde til fremstillingen og anvendelse af protozo-kulturer
DK1730109T3 (da) Syntese af pyrrol-2-carbonitriler
DK1611083T3 (da) Syntese af 2-chlormethyl-6-methylbenzoesyreestere
DK1948609T3 (da) Fremgangsmåde til fremstilling af pyridylcarboxylsyreamider og estere
DOP2005000058A (es) Sintesis de compuestos de ester y acido borico
ITMO20040001A1 (it) Mezzi di contenimento